Blood Plasma Derivatives Market (By Type: Albumin, Factor 8, Factor 9, Immunoglobulin, Hyper Immune Globulin, Others; By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willerbrands Disease (VWD), Other; By End-User: Hospitals, Clinics, Other) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Blood Plasma Derivatives

1.1. Definition and Scope 

1.1.1. Definition of Blood Plasma Derivatives

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Blood Plasma Derivatives Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Blood Plasma Derivatives Market By Type

1.2.3. Blood Plasma Derivatives Market By Application

1.2.4. Blood Plasma Derivatives Market By End-User

1.2.5. Blood Plasma Derivatives Market by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Blood Plasma Derivatives Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Blood Plasma Derivatives Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Blood Plasma Derivatives Major Manufacturers in 2019

CHAPTER 5. Blood Plasma Derivatives Market By Type

5.1. Introduction

5.2. Blood Plasma Derivatives Revenue By Type

5.2.1. Blood Plasma Derivatives Revenue (US$ Mn) and Forecast, By Type, 2016-2027

5.2.2. Albumin

5.2.2.1. Albumin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.3. Factor 8

5.2.3.1. Factor 8 Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.4. Factor 9

5.2.4.1. Factor 9 Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.5. Immunoglobulin

5.2.5.1. Immunoglobulin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.6. Hyper Immune Globulin

5.2.6.1. Hyper Immune Globulin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.7. Other Applications

5.2.7.1. Other Applications Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Blood Plasma Derivatives Market Revenue By Application

6.1. Introduction

6.2. Blood Plasma Derivatives Revenue (US$ Mn) By Application

6.2.1. Blood Plasma Derivatives Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

6.2.2. Hemophilia

6.2.2.1. Hemophilia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.3. Hypogammaglobulinemia

6.2.3.1. Hypogammaglobulinemia Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.4. Immunodeficiency Diseases

6.2.4.1. Immunodeficiency Diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.5. Von Willerbrands Disease (VWD)

6.2.5.1. Von Willerbrands Disease (VWD) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.6. Other Applications

6.2.6.1. Other Applications Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. Blood Plasma Derivatives Market By End-User 

7.1. Introduction

7.2. Blood Plasma Derivatives Revenue (US$ Mn) By End-User

7.2.1. Blood Plasma Derivatives Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.3. Clinics

7.2.3.1. Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

7.2.4. Other End-Users

7.2.4.1. Other End-Users Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 8. North America Blood Plasma Derivatives Market By Country 

8.1. North America Blood Plasma Derivatives Overview

8.2. U.S.

8.2.1. U.S. Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

8.2.2. U.S. Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.2.3. U.S. Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

8.3. Canada

8.3.1. Canada Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

8.3.2. Canada Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.3.3. Canada Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

8.4. North America PEST Analysis

CHAPTER 9. Europe Blood Plasma Derivatives Market By Country

9.1. Europe Blood Plasma Derivatives Market Overview

9.2. U.K.

9.2.1. U.K. Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.2.2. U.K. Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.2.3. U.K. Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.3. Germany

9.3.1. Germany Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.3.2. Germany Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.3.3. Germany Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.4. France 

9.4.1. France Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.4.2. France Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.4.3. France Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.5. Spain

9.5.1. Spain Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.5.2. Spain Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.5.3. Spain Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.6. Rest of Europe

9.6.1. Rest of Europe Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016-2027

9.6.2. Rest of Europe Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

9.6.3. Rest of Europe Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016-2027

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Blood Plasma Derivatives Market By Country

10.1. Asia Pacific Blood Plasma Derivatives Market Overview

10.2. China

10.2.1. China Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.2.2. China Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.2.3. China Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.3. Japan

10.3.1. Japan Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.3.2. Japan Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.3.3. Japan Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.4. India

10.4.1. India Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.4.2. India Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.4.3. India Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.5. Australia

10.5.1. Australia Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.5.2. Australia Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.5.3. Australia Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.6. South Korea

10.6.1. South Korea Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.6.2. South Korea Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.6.3. South Korea Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

10.7.2. Rest of Asia-Pacific Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.7.3. Rest of Asia-Pacific Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Blood Plasma Derivatives Market By Country

11.1. Latin America Blood Plasma Derivatives Market Overview

11.2. Brazil

11.2.1. Brazil Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

11.2.2. Brazil Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

11.2.3. Brazil Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

11.3. Mexico

11.3.1. Mexico Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

11.3.2. Mexico Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

11.3.3. Mexico Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

11.4. Rest of Latin America

11.4.1. Rest of Latin America Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

11.4.2. Rest of Latin America Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027

11.4.3. Rest of Latin America Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 – 2027

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Blood Plasma Derivatives Market By Country 

12.1. Middle East & Africa Blood Plasma Derivatives Market Overview

12.2. Saudi Arabia

12.2.1. Saudi Arabia Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

12.2.2. Saudi Arabia Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

12.2.3. Saudi Arabia Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

12.3. UAE

12.3.1. UAE Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

12.3.2. UAE Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

12.3.3. UAE Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 - 2027

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027

12.4.2. Rest of Middle East & Africa Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

12.4.3. Rest of Middle East & Africa Blood Plasma Derivatives Market Revenue (US$ Mn) and Forecast By End-User, 2016 – 2027

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Blood Plasma Derivatives

13.1. Blood Plasma Derivatives Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Blood Plasma Derivatives Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE

14.1. Grifols, S.A.

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (US$ Mn), 2019

14.1.3.2. Grifols, S.A. 2019 Blood Plasma Derivatives Business Regional Distribution

14.1.4. Product/ Service and Specification

14.1.5. Recent Developments & Business Strategy

14.1.6. Manufacturing Plant Footprint Analysis

14.2. SK Plasma

14.3. Fusion Healthcare

14.4. Biotest AG

14.5. GC Pharma [Green Cross Corporation]

14.6. Baxter International Inc.

14.7. LFB S.A.

14.8. Octapharma AG

14.9. CSL Limited

14.10. Shire plc

14.11. Others